Khanani A, Campochiaro P, Graff J, Marcus D, Miller D, Mittra R
JAMA Ophthalmol. 2025; .
PMID: 40048197
PMC: 11886869.
DOI: 10.1001/jamaophthalmol.2025.0006.
Pieramici D, Awh C, Chang M, Emanuelli A, Holekamp N, Hu A
JAMA Ophthalmol. 2025; .
PMID: 40048178
PMC: 11886866.
DOI: 10.1001/jamaophthalmol.2025.0001.
Moreno-Gonzalez J, Reza-Lopez S, Gonzalez-Rodriguez E, Siqueiros-Cendon T, Escareno Contreras A, Rascon-Cruz Q
Genes (Basel). 2025; 16(2).
PMID: 40004467
PMC: 11855146.
DOI: 10.3390/genes16020139.
But V, Rus V, Ilyes T, Gherman M, Stanescu I, Bolboaca S
Antioxidants (Basel). 2025; 14(2).
PMID: 40002353
PMC: 11851820.
DOI: 10.3390/antiox14020166.
Strelow B, Herndon J, McMahon A, Takagi M, McCoy R, Olson R
Diabetes Spectr. 2025; 38(1):33-40.
PMID: 39959520
PMC: 11825403.
DOI: 10.2337/ds24-0005.
Assessing the Role of Asymmetric Dimethylarginine in Endothelial Dysfunction: Insights Into Cardiovascular Risk Factors.
Sonkar S, Verma J, Sonkar G, Gupta A, Singh A, Vishwakarma P
Cureus. 2025; 17(1):e77565.
PMID: 39958038
PMC: 11830118.
DOI: 10.7759/cureus.77565.
Developing a Quality Improvement Framework to Enhance the Health System User Experience for Individuals Living With Type 1 Diabetes: The Reshape T1D Study.
Boisvenue J, Elezzabi Y, Young K, Gibson K, Hinz H, McClure R
Health Expect. 2025; 28(1):e70172.
PMID: 39910931
PMC: 11799594.
DOI: 10.1111/hex.70172.
Low-carbohydrate diet for people with type 2 diabetes mellitus.
Burgos M, Ivaldi D, Oltra G, Escobar Liquitay C, Garegnani L
Cochrane Database Syst Rev. 2025; 5:CD015954.
PMID: 39908069
PMC: 11131143.
DOI: 10.1002/14651858.CD015954.
Impact of the family doctor system on medication adherence among type 2 diabetes patients in China: a difference-in-differences analysis.
Tong X, Zou H, Zhang L, Chen W
BMC Public Health. 2025; 25(1):404.
PMID: 39891108
PMC: 11786533.
DOI: 10.1186/s12889-025-21656-0.
Dear Health Care Professional: What People Need and Want When Diagnosed With Type 2 Diabetes.
Boakye M, Miyamoto S, Greenwood D, Boltz M, Kraschnewski J, Van Haitsma K
Clin Diabetes. 2025; 43(1):148-155.
PMID: 39829710
PMC: 11739357.
DOI: 10.2337/cd23-0105.
Cardiovascular outcomes of SGLT-2 inhibitors' subtypes in type 2 diabetes; an updated systematic review and meta-analysis of randomized controlled trials.
Ebrahimi P, Soleimani H, Mahalleh M, Farisi P, Taheri M, Ramezani P
J Diabetes Metab Disord. 2025; 24(1):47.
PMID: 39816986
PMC: 11730052.
DOI: 10.1007/s40200-024-01545-w.
Sociodemographic factors, clinical characteristics, outcomes and short-term follow-up in COVID-19 patients with new onset hyperglycemia and pre-existing diabetes on admission in a tertiary-care hospital in Bangladesh.
Sultana Kakoly N, Hasan S, Hoque M, Ratul R, Khan M, Mitra D
PLoS One. 2024; 19(12):e0311508.
PMID: 39700129
PMC: 11658473.
DOI: 10.1371/journal.pone.0311508.
Integrative analysis of toxicometabolomics and toxicoproteomics data: new molecular insights into thiazolidinedione-induced cardiotoxicity.
Al Sultan A, Rattray Z, Rattray N
Metabolomics. 2024; 21(1):1.
PMID: 39636558
PMC: 11621136.
DOI: 10.1007/s11306-024-02201-3.
Complement C3 promotes islet β-cell dedifferentiation by activating Wnt/β-catenin pathway.
Zhuang L, Li Q, You W, Wen S, Chen T, Su J
iScience. 2024; 27(10):111064.
PMID: 39635125
PMC: 11615230.
DOI: 10.1016/j.isci.2024.111064.
Comparative risk of type 2 diabetes development between women with gestational diabetes and women with impaired glucose tolerance over two decades: a multiethnic prospective cohort in New Zealand.
Yu D, Fu H, Zhao Z, Pickering K, Baker J, Cutfield R
BMJ Open Diabetes Res Care. 2024; 12(6.
PMID: 39631843
PMC: 11660319.
DOI: 10.1136/bmjdrc-2024-004210.
iDiabetes platform-enhanced phenotyping of patients with diabetes for precision diagnosis, prognosis and treatment: study protocol for a cluster-randomised controlled study in Tayside, Scotland.
Lin Y, Leith D, Abbott M, Barrett R, Bell S, Croudace T
BMJ Open. 2024; 14(11):e086594.
PMID: 39613429
PMC: 11605812.
DOI: 10.1136/bmjopen-2024-086594.
Impact of Multistrain Probiotic Supplementation on Glycemic Control in Type 2 Diabetes Mellitus-Randomized Controlled Trial.
Chaithanya V, Kumar J, Leela K, Ram M, Thulukanam J
Life (Basel). 2024; 14(11).
PMID: 39598282
PMC: 11595758.
DOI: 10.3390/life14111484.
Insights from Team Clinic: A Person-Centered Virtual Peer Group Care Model Adapted for Marginalized and Historically Excluded Youth with Type 1 Diabetes (T1D).
Flores Garcia J, Reid M, Torres Sanchez A, Ruelas V, Salvy S, Thomas A
Children (Basel). 2024; 11(11).
PMID: 39594958
PMC: 11592975.
DOI: 10.3390/children11111383.
Diabetes Management: A Case Study to Drive National Policy Change in Primary Care Settings.
Bannuru R, Prieto F, Murdock L, Tollefson E
Ann Fam Med. 2024; 22(6):550-556.
PMID: 39586698
PMC: 11588362.
DOI: 10.1370/afm.3175.
Activation of the HPA Axis Does Not Explain Nonresponsiveness to GLP-1R Agonist Treatment in Individuals With Type 2 Diabetes.
Tokgoz S, Boss M, Jansen T, Jansen T, Meijer R, Frielink C
Diabetes. 2024; 74(2):212-222.
PMID: 39561332
PMC: 11755685.
DOI: 10.2337/db24-0463.
